Table 1 Baseline characteristics of the study population
overall population (n = 231) | patients with a thrombus (n = 50) | patients without a thrombus (n = 181) | p-value | |
|---|---|---|---|---|
Age | 83 ± 5.6 | 85 ± 4.3 | 83 ± 5.8 | 0.086 |
BMI | 26 ± 5.2 | 25 ± 4.1 | 26 ± 5.4 | p < 0.05 |
Male | 120 (51.9%) | 30 (60.0%) | 90 (49.7%) | 0.206 |
Dyslipidaemia | 121 (52.5%) | 17 (34.0%) | 104 (57.5%) | p < 0.05 |
Hypertension | 215 (93.1%) | 46 (92.0%) | 169 (93.4%) | 0.755 |
Diabetes | 67 (29.0%) | 13 (26.0%) | 54 (29.8%) | 0.725 |
Heart failure | 121 (52.4%) | 27(54.0%) | 94 (51.9%) | 0.873 |
CHA2DS2-VASc | 5 ± 1.1 | 5 ± 1.0 | 5 ± 1.1 | 0.522 |
LA diameter | 53 ± 8.0 | 55 ± 6.0 | 52 ± 8.4 | 0.162 |
Cardiomegaly | 57 (24.7%) | 18 (36.0%) | 39(21.5%) | p < 0.05 |
Anticoagulants | 158 (68.4%) | 36 (72.0%) | 122 (67.4%) | 0.608 |